Hypera Buys Boehringer’s Buscopan in Brazil
Hypera has agreed to pay BRL1.3bn to acquire the rights in Brazil to Buscopan and Buscofem from Boehringer Ingelheim.
Hypera has agreed to pay BRL1.3bn to acquire the rights in Brazil to Buscopan and Buscofem from Boehringer Ingelheim.